Medication safety in obstetrics and gynecology

Clinical Obstetrics and Gynecology

Volumn 53, Issue 3, 2010, Pages 482-499

  Ciarkowski, Scott L ^a   Stalburg, Caren M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; CARBOPROST TROMETAMOL; HEPARIN; HYDROMORPHONE; MAGNESIUM SULFATE; MISOPROSTOL; OPIATE DERIVATIVE; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E2; TERATOGENIC AGENT;

CLINICAL PROTOCOL; COUNSELING; DELIVERY; DRUG SAFETY; GYNECOLOGY; HUMAN; INTERPERSONAL COMMUNICATION; LABOR; MEDICAL PRACTICE; MEDICATION ERROR; OBSTETRICS; OUTPATIENT; PATIENT SAFETY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRESCRIPTION; REVIEW;

AMBULATORY CARE; ANALGESICS; ANTICOAGULANTS; DOCUMENTATION; DRUG PRESCRIPTIONS; FEMALE; FETUS; HANDWRITING; HEPARIN; HUMANS; MAGNESIUM SULFATE; MEDICATION ERRORS; NEUROPROTECTIVE AGENTS; OXYTOCICS; OXYTOCIN; PREGNANCY; PREGNANCY COMPLICATIONS; PROSTAGLANDINS; SAFETY MANAGEMENT; TRIAGE;

EID: 77955104907     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181ec14c0     Document Type: Review

References (34)

1. ACOG Committee Opinion No. 447. Patient safety in obstetrics and gynecology. Obstet Gynecol. 2009;114:1424-1427.
2. Glover DD, Amonkar M, Rybeck BF, et al. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Obstet Gynecol. 2003;188: 1039-1045.
3. Kfuri TA, Morlock L, Hicks RW, et al. Medication errors in obstetrics. Clin Peri- natol. 2008;35:101-117.
4. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274:35-43.
5. Murdock LJ, Cameron VL. Smart infusion technology: a minimum safety standard for intensive care? Br J Nurs. 2008; 17:630-636.
6. Morriss FH, Abramowitz PW, Nelson SP, et al. Effectiveness of a barcode medication administration system in reducing preventable adverse drug events in a neonatal intensive care unit: a prospective cohort study. J Pediatr. 2009;154:363-368.
7. Reckmann MH, Westbrook JI, Koh Y, et al. Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc. 2009;16:613-623.
8. ACOG Committe Opinion No. 33. Safe use of medication. Obstet Gynecol. 2006; 107:969-972.
9. The Joint Commission. Official "Do not use" List. http://www.jointcommissio- n.org/NR/rdonlyres/2329F8F5-6EC5-4E21- B932-54B2B7D53F00/0/dnu-list.pdf. Updated 2005. [Accessed on November 16, 2009].
10. The Joint Commission. Sentinel Event Alert, Issue 43: Leadership committed to safety. SentinelEvents/SentinelEventAlert/sea-43. htm. Updated 2009. [Accessed on October 29, 2009].
11. Clark S, Belfort M, Byrum S, et al. Improved outcomes, fewer cesarean deliveries, and reduced litigation: results of a new paradigm in patient safety. Obstet Gynecol. 2008;199:105.e1-105.e7.
12. Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf 2000 23 245-253
13. Buhimschi C, Weiner C. Medications in pregnancy and lactation: part 1. Teratology. Obstet Gynecol. 2009;113:166-188.
14. United States Food and Drug Administration. Consumer information for women. www.fda.gov/womens/registries.
15. Institute for Safe Medication Practices. Fatal outcome after inadvertent injection of topical epinephrine [ISMP web site]. March 26, 2009. Available at: http://www.ISMP.org/Newsletters/acutecare/articles/20090326.asp. [Accessed on April 8, 2010].
16. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non- anesthesiologists. Anesthesiology. 2002;96: 1004-1017.
17. Clark S, Simpson K, Knox GE, et al. Oxytocin: new perspectives on an old drug. Am J Obstet Gynecol. 2009;200: 35.e1-35.e6.
18. Seitchik J, Amico JA, Robinson AG, et al. Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacoki- netics. Obstet Gynecol. 1984;150:225-228.
19. Simpson K, James D. Effects of oxytocin- induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Obstet Gynecol. 2008;199:34.e1-34.e5.
20. Simpson K, Knox GE. Oxytocin as a high-alert medication: implications for perinatal patient safety. MCN Am J Ma- tern Child Nurs. 2009;34:8-15.
21. Clark S, Belfort M, Saade G, et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol. 2007;197:480.e1-480.e5.
22. Mercer B, Merlino A. Magnesium sulfate for preterm labor and preterm birth. Am J Obstet Gynecol. 2009;114:650-668.
23. Simpson K, Knox GE. Obstetrical accidents involving intravenous magnesium sulfate: recommendations to promote patient safety. MCN Am J Matern Child Nurs. 2004;29:161-169.
24. Robertson RD, Robinson MA, Mujumdar JR, et al. Therapeutic error: carboprost tromethamine given to a newborn intramuscularly. Internet J Pediatr Neonatol. 2007;6:2.
25. Reedy MB, McMillion JS, Engvall WR, et al. Inadvertent administration of prostaglandin E1 instead of prostaglandin F2 alpha in a patient with uterine atony and hemorrhage. Obstet Gynecol. 1992;79: 890-894.
26. Schein J, Hicks R, Nelson W, et al. Patient- controlled analgesia-related medication errors in the postoperative period: causes and prevention. Drug Saf. 2009;32:549-559.
27. Carvalho B. Respiratory depression after neuraxial opioids in the obstetric setting. Anesth Analg. 2008;107:956-961.
28. Smetzer J, Baker C, Byrne FD, et al. Shaping systems for better behavioral choices: lessons learned from a fatal medication error. Jt Comm J Qual Patient Saf. 2010;36: 152-163.
29. Lee WM. Acetaminophen and the US. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatol- ogy. 2004;40:6-9.
30. Simpson KR. Medication safety with he- parin. MCN Am J Matern Child Nurs. 2008;33:135.
31. George J, Bernstein RS. Using electronic medical records to reduce errors and risks in a prenatal network. Curr Opin Obstet Gynecol. 2009;21:527-531.
32. Cescon DW, Etchells E. Barcoded medication administration: a last line of defense. JAMA. 2008;299:2200-2202.
33. Hertzel C, Sousa V. The use of smart pumps for preventing medication errors. J Infus Nurs. 2009;32:257-267.
34. Pettker C, Thung S, Norwitz E, et al. Impact of a comprehensive patient safety strategy on obstetric adverse events. Am J Obstet Gynecol. 2009;200:492.e1-492.e8.